FINANCIAL ACCOUNTING • LONG-LIVED ASSETS

Intangible Assets & Amortization — Identify intangible assets and record amortization

Learn to recognize, measure, and systematically expense the non-physical resources that drive modern business value.

Historical Context & Motivation

For most of industrial history, the balance sheet was dominated by tangible, physical assets—factories, land, machinery, and inventory. When firms like Carnegie Steel or Standard Oil prepared financial statements in the late nineteenth century, the assets they reported were overwhelmingly things you could see and touch. The notion that a patent, a trademark, or a contractual right could carry significant economic value on its own was acknowledged in law but rarely given systematic treatment in accounting records. As the economy shifted from manufacturing toward services, technology, and intellectual property, this gap became untenable.

The rise of mergers and acquisitions in the twentieth century forced the accounting profession to confront goodwill—the premium a buyer pays above the fair value of identifiable net assets. Debates raged for decades over whether goodwill should be written off immediately, amortized over an arbitrary life, or left on the books indefinitely. Similar questions arose for internally developed research, brand names, and franchise agreements. Standard-setters eventually produced the frameworks that govern today's practice, most notably ASC 350 (formerly SFAS 142) and IAS 38, which together define how firms identify, measure, and amortize or impair intangible assets.

1944
ARB No. 24 — Early Goodwill Guidance
The AICPA's Committee on Accounting Procedure issued Accounting Research Bulletin No. 24, providing early guidance on writing off intangibles, including goodwill, over their estimated useful lives.
1970
APB Opinion No. 17
The Accounting Principles Board required all intangible assets to be amortized over a period not exceeding 40 years, establishing the first systematic U.S. standard for intangible amortization.
1998
IAS 38 — Intangible Assets
The IASC (now IASB) issued IAS 38, creating a comprehensive international framework distinguishing finite-life intangibles (amortized) from indefinite-life intangibles (tested for impairment annually).
2001
SFAS 142 (now ASC 350)
FASB eliminated the mandatory 40-year amortization of goodwill, replacing it with an annual impairment test. Identifiable intangibles with finite lives continued to be amortized; those with indefinite lives were tested for impairment instead.
2014–Present
Ongoing Convergence & Simplification
FASB and IASB continue to refine guidance, including simplified goodwill impairment tests (ASU 2017-04) and ongoing debates about whether to reintroduce goodwill amortization for public entities.

The central question these standards address is deceptively simple: when a firm acquires or develops a resource that has no physical substance but generates future economic benefits, how should it report that resource and systematically reduce its carrying amount as those benefits are consumed? Understanding the answer requires clarity on what qualifies as an intangible asset, how its cost is determined, and how amortization allocates that cost to the periods that benefit from the asset.

Core Principles & Definitions

An intangible asset is an identifiable, non-monetary asset without physical substance that is controlled by the entity and expected to provide future economic benefits. The three-part definition—identifiability, control, and future benefit—mirrors the general asset-recognition criteria in the conceptual framework, but the absence of physical form introduces unique measurement and valuation challenges. Unlike a piece of equipment whose remaining usefulness can be estimated from wear patterns, an intangible's useful life may depend on legal protections, competitive dynamics, or technological change.

1

Identifiability

An intangible is identifiable if it is separable (can be sold, transferred, or licensed independently) or arises from contractual or legal rights. This criterion distinguishes specific intangibles from the residual category of goodwill.
2

Control & Ownership

The entity must have the power to obtain future economic benefits from the asset and restrict others' access. Legal rights (patents, copyrights) usually establish control, though contractual arrangements can serve the same function.
3

Future Economic Benefit

The asset must be expected to generate future revenues, reduce costs, or provide other economic advantages. If benefits are uncertain or immaterial, the expenditure is typically expensed immediately.
4

Finite vs. Indefinite Life

Intangibles with a determinable useful life are amortized over that life. Those with no foreseeable limit to their benefit period are classified as indefinite-life and tested for impairment annually rather than amortized.
5

Amortization as Cost Allocation

Amortization is the systematic allocation of an intangible asset's depreciable amount over its useful life. It parallels depreciation for tangible assets and depletion for natural resources, matching cost to the periods that receive benefit.
KEY TAKEAWAY
Think of an intangible asset like a prepaid subscription to a streaming service. You pay upfront for a future benefit (content access), and each month a portion of that prepaid cost "expires" as you consume the benefit. Amortization works the same way: the firm paid for a right or capability, and each accounting period absorbs a share of that cost as the asset's benefits are consumed. When the subscription has no definite end date—like a perpetual trademark—you do not amortize it; instead, you periodically check whether the service is still worth what you paid.

Visual Explanation — Intangible Asset Landscape

The diagram above illustrates the two-tier classification of intangible assets. At the top level, intangibles divide into finite-life assets (amortized systematically) and indefinite-life assets (subject to annual impairment testing). The lower portion shows three acquisition pathways, each with distinct initial recognition rules.

Notice the fundamental asymmetry in accounting treatment depending on how the intangible is obtained. When a firm purchases a patent from a third party, the purchase price is capitalized and placed on the balance sheet; the asset then runs through amortization expense over its useful life. In a business combination, the acquirer must identify and separately value each intangible that meets the identifiability criterion—brand names, non-compete agreements, technology—and only the residual goes to goodwill. Internally generated intangibles, by contrast, are largely expensed under U.S. GAAP because the costs of creation (R&D) are difficult to link reliably to specific future benefits. IFRS permits capitalization of development costs once strict criteria are met (IAS 38.57), creating an important distinction for students who will encounter both frameworks.

Mathematical Framework — Amortization Calculations

The mechanics of amortization closely mirror straight-line depreciation. The depreciable amount of an intangible asset is its cost (or revalued amount under IFRS) minus any residual value. In practice, intangible residual values are almost always zero because there is rarely a liquid secondary market and GAAP requires the residual to be verifiable. The depreciable amount is then allocated evenly across the useful life, defined as the shorter of the legal life and the economic life. GAAP and IFRS both allow other systematic methods if they better reflect the pattern of benefit consumption, but straight-line remains the default absent compelling evidence otherwise.

STRAIGHT-LINE AMORTIZATION
Annual Amortization Expense = (Cost − Residual Value) ÷ Useful Life
Where Cost = purchase price plus directly attributable expenditures; Residual Value = estimated amount recoverable at end of useful life (typically $0 for intangibles); Useful Life = the lesser of legal life or expected economic benefit period, in years.
CARRYING AMOUNT (BOOK VALUE)
Carrying Amount = Cost − Accumulated Amortization − Impairment Losses
The carrying amount represents the net book value reported on the balance sheet at any given date. Accumulated Amortization is a contra-asset account that increases each period. Any recognized impairment losses further reduce the carrying amount.
UNITS-OF-ACTIVITY AMORTIZATION (ALTERNATIVE METHOD)
Amortization Expense = (Cost − Residual Value) × (Units Produced This Period ÷ Total Estimated Units)
This method is used when the benefit pattern is tied to usage rather than time. For example, a patent on a manufacturing process might be amortized based on units produced under the patent, providing a closer match of expense to revenue.
📝 Journal Entry Template
The periodic amortization entry debits Amortization Expense (income statement) and credits either Accumulated Amortization (contra-asset on the balance sheet) or credits the intangible asset account directly. Under U.S. GAAP, both approaches are acceptable; most firms use the contra-asset method to preserve historical cost information. The entry is: Dr. Amortization Expense XX / Cr. Accumulated Amortization—Intangible Asset XX.

Detailed Classification of Intangible Assets

Intangible assets span a wide spectrum. The table below categorizes common intangibles by their source, typical useful life classification, and the accounting treatment that follows. Mastering this taxonomy is essential for correctly applying GAAP or IFRS rules, particularly in purchase-price allocation scenarios where an acquirer must separately identify every intangible that meets the recognition criteria before assigning any residual to goodwill.

Common Intangible Assets — Classification and Treatment
Intangible AssetSource / OriginLife ClassificationTypical Useful LifeAccounting Treatment
PatentLegal grant; purchased or developedFiniteLegal: 20 yrs; Economic: often shorterAmortize over shorter of legal or economic life
CopyrightLegal right; automatic upon creationFiniteLegal: creator's life + 70 yrs; Economic: variesAmortize over estimated economic life
Franchise / LicenseContractual agreementFinite (usually)Per contract termAmortize over franchise/license term
Trademark / Trade NameLegal registration; renewableIndefiniteRenewable indefinitely at low costNo amortization; annual impairment test
GoodwillBusiness combination onlyIndefinite (GAAP) / see note (IFRS)N/AGAAP: impairment only; IFRS: same currently
Customer RelationshipsBusiness combinationFiniteEstimated attrition periodAmortize; often accelerated methods
Software (Internal Use)Internally developedFinite3–7 years typicalCapitalize after preliminary stage; amortize
This step-chart illustrates how a $120,000 patent with a 10-year useful life is amortized using the straight-line method. The cyan staircase shows the declining carrying amount, while the amber bars represent the growing accumulated amortization. Each year, $12,000 of expense is recognized, and by year 10 the carrying amount reaches zero.

Worked Example — Patent Acquisition & Amortization

On January 1, Year 1, TechNova Corp. purchases a patent from an independent inventor for $180,000 cash. TechNova also pays $12,000 in legal fees to register the patent transfer and $8,000 to an outside consultant who evaluated the patent's commercial viability. The patent has a remaining legal life of 15 years, but TechNova estimates the technology will be economically useful for only 10 years due to anticipated technological obsolescence. The residual value is zero. TechNova uses the straight-line method and a calendar fiscal year. Prepare the journal entries for Year 1.

Patent Acquisition & Year 1 Amortization
1
Step 1 — Determine the Capitalizable CostAll costs directly attributable to acquiring the patent and bringing it to its intended use are capitalized. The purchase price is $180,000, the legal fees are $12,000, and the consulting evaluation fee of $8,000 is directly attributable to the acquisition. Total capitalizable cost = $180,000 + $12,000 + $8,000.
Cost of Patent = $200,000
2
Step 2 — Record the Acquisition Journal Entry (January 1, Year 1)Debit the intangible asset account and credit Cash for the total capitalizable cost. The entry is: Dr. Patent $200,000 / Cr. Cash $200,000. This places the patent on the balance sheet as a non-current asset.
Dr. Patent $200,000 | Cr. Cash $200,000
3
Step 3 — Determine the Useful LifeThe useful life for amortization purposes is the shorter of the legal life (15 years remaining) and the economic life (10 years estimated). Since the economic life is shorter, the patent will be amortized over 10 years.
Useful Life = 10 years
4
Step 4 — Calculate Annual Amortization ExpenseApply the straight-line formula: Annual Amortization = (Cost − Residual Value) ÷ Useful Life = ($200,000 − $0) ÷ 10 = $20,000 per year.
Annual Amortization Expense = $20,000
5
Step 5 — Record the Year 1 Amortization Entry (December 31, Year 1)Debit Amortization Expense to recognize the cost on the income statement and credit Accumulated Amortization—Patent to reduce the net carrying amount of the patent on the balance sheet. After this entry, the carrying amount is $200,000 − $20,000 = $180,000.
Dr. Amortization Expense $20,000 | Cr. Accumulated Amortization—Patent $20,000. Carrying Amount = $180,000
⚠️ What About R&D Costs?
If TechNova had internally developed this patent, U.S. GAAP would require the research and development expenditures to be expensed as incurred (ASC 730). Only the legal fees to obtain the patent itself could be capitalized. Under IFRS, development costs meeting the six criteria in IAS 38.57 (technical feasibility, intention to complete, ability to use or sell, probable future benefits, availability of resources, and reliable measurement) may be capitalized, potentially resulting in a larger intangible asset on the balance sheet.

GAAP vs. IFRS — Key Differences

While U.S. GAAP and IFRS share a common conceptual foundation for intangible assets, several important differences affect recognition, measurement, and subsequent reporting. Students who will work in multinational firms or public accounting must understand these distinctions, as they can materially affect reported assets and earnings across jurisdictions.

Key GAAP vs. IFRS Differences for Intangible Assets
IssueU.S. GAAP (ASC 350 / ASC 730)IFRS (IAS 38)
Research CostsExpense as incurredExpense as incurred
Development CostsExpense as incurred (with narrow exceptions for software)Capitalize if six criteria in IAS 38.57 are met
Revaluation ModelNot permitted; historical cost onlyPermitted if active market exists (rare in practice)
Goodwill AmortizationNot amortized; tested for impairment annuallyNot amortized; tested for impairment annually (IASB reviewing potential amortization reintroduction)
Impairment ReversalProhibited for all assets (except certain held-for-sale)Permitted for intangibles (not goodwill) if conditions warrant
Amortization MethodStraight-line default; other methods permitted if pattern is determinableMethod reflecting pattern of benefits; straight-line is rebuttable presumption
KEY TAKEAWAY
The most impactful difference is the treatment of internally generated development costs. Under IFRS, a pharmaceutical company that achieves clinical-trial milestones may begin capitalizing development outlays, creating a balance-sheet asset that a U.S. GAAP reporter would have already expensed. This means identical economic activities can produce materially different financial statements depending on the reporting framework—a critical consideration when comparing companies across borders or analyzing firms that present reconciliations between standards.

Impairment Testing & Advanced Considerations

Amortization is not the only mechanism by which an intangible asset's carrying amount may decrease. When events or circumstances suggest that an asset's carrying amount may not be recoverable—a competitor launches a superior product, a regulatory change undermines a license, or a brand suffers reputational damage—the firm must perform an impairment test. For indefinite-life intangibles and goodwill, this test is mandatory at least annually. Understanding how impairment interacts with amortization is essential for a complete picture of intangible asset accounting.

Amortization vs. Impairment — Side-by-Side Comparison
FeatureAmortization (Finite-Life Intangibles)Impairment (All Intangibles & Goodwill)
PurposeSystematic allocation of cost over useful lifeRecognition of a sudden or unexpected decline in value
FrequencyEvery reporting period (monthly, quarterly, or annually)When triggering events occur; annually for indefinite-life and goodwill
Measurement(Cost − Residual) ÷ Useful LifeGAAP: Carrying amount vs. fair value; IFRS: Carrying amount vs. recoverable amount
ReversibilityNot applicable (adjustments made prospectively if life changes)GAAP: never reversed; IFRS: may be reversed (except goodwill)
Income Statement EffectAmortization expense (operating)Impairment loss (often below operating income or in separate line)

An important advanced topic is the revision of useful life estimates. If new information suggests that a patent will become obsolete sooner than originally projected, the firm does not restate prior periods. Instead, it revises the amortization prospectively: the remaining carrying amount is spread over the new, shorter remaining life. Similarly, if an indefinite-life intangible is reclassified to finite-life (for example, a trademark the firm decides not to renew), amortization begins at that point over the newly estimated useful life. These topics bridge directly into intermediate and advanced accounting courses, where students explore impairment testing mechanics, purchase-price allocations in greater detail, and the interplay between tax and book amortization under ASC 740.

Practice Problems

PROBLEM 1CONCEPTUAL
A company has a well-known brand name that it developed internally over the past 20 years through advertising and quality products. Should this brand name appear as an intangible asset on the balance sheet under U.S. GAAP? Explain the reasoning behind the standard's treatment.
PROBLEM 2BASIC CALCULATION
On July 1, Year 1, Harper Industries purchases a copyright for $90,000 cash. The copyright has a remaining legal life of 30 years, but Harper estimates the economic life of the copyrighted material is 15 years. Residual value is $0. Using straight-line amortization and a December 31 fiscal year-end, calculate the amortization expense for Year 1 and the carrying amount of the copyright on December 31, Year 1.
PROBLEM 3INTERMEDIATE
Redfield Corp. acquired a patent on January 1, Year 1 for $250,000. The patent has a remaining legal life of 12 years, and the estimated economic life is 10 years. Redfield uses straight-line amortization with $0 residual value. At the end of Year 4, new technology makes the patent less competitive, and Redfield revises the remaining economic life to 3 more years (from the original 6 remaining). Calculate (a) total amortization recorded in Years 1–4, (b) the revised annual amortization for Years 5–7, and (c) the carrying amount at the end of Year 7.
PROBLEM 4APPLIED
GlobalMed Inc., a U.S. GAAP reporter, acquires BioPharm Ltd. for $5,000,000 cash. At the acquisition date, the fair values of BioPharm's identifiable assets are: tangible assets $2,200,000; developed technology (patent portfolio) $800,000 with an estimated 8-year useful life; customer relationships $400,000 with an estimated 5-year useful life; and trade name $300,000 considered to have an indefinite life. BioPharm's liabilities total $1,100,000. Calculate the goodwill arising from the acquisition and the total intangible amortization expense GlobalMed will record in Year 1.
PROBLEM 5CRITICAL THINKING
A technology startup spends $2 million on R&D to develop a proprietary algorithm. Under U.S. GAAP, the entire amount is expensed. Under IFRS, assume the company can demonstrate that it meets all six IAS 38.57 criteria after spending the first $800,000 on research, and the remaining $1,200,000 qualifies as capitalizable development costs. Discuss how this difference affects (a) total assets, (b) net income in the development year, and (c) net income in subsequent years when the algorithm is amortized over 5 years. What are the implications for financial statement comparability and analyst interpretation?

Lesson Summary

Intangible assets are identifiable, non-monetary resources without physical substance that provide future economic benefits—examples include patents, copyrights, franchises, trademarks, and goodwill. Assets with a finite useful life are amortized systematically—typically straight-line—over the shorter of their legal or economic life, with the formula (Cost − Residual Value) ÷ Useful Life. Assets with an indefinite life are not amortized but are instead tested for impairment at least annually.

Under U.S. GAAP, most internally generated intangibles (including R&D) are expensed as incurred, while IFRS permits capitalization of development costs that meet specific criteria, creating a significant comparability issue across jurisdictions. The periodic journal entry debits Amortization Expense and credits Accumulated Amortization, mirroring the depreciation framework for tangible assets. When circumstances change, useful life revisions are handled prospectively, spreading the remaining carrying amount over the revised remaining life. Mastering these concepts prepares you for purchase-price allocation analysis, impairment testing, and the broader evaluation of how firms report the intellectual capital that increasingly drives modern enterprise value.

Varsity Tutors • Financial Accounting • Intangible Assets & Amortization